Analyses of publicly available ChIP-seq data demonstrated the presence of strong H3K27ac at the promoter region in five clinical RTK I (receptor tyrosine kinase I, commonly with PDGFRA gene amplifications and similar to the PN subtype) and four MES GBM specimens (Figure S6A, B). This evidence concerns the gene PDGFRA and glioblastoma.